117 related articles for article (PubMed ID: 10221351)
1. Antiatherosclerotic effect of alacepril, an angiotensin-converting enzyme inhibitor, in monkeys fed a high-cholesterol diet.
Miyazaki M; Takai S
Hypertens Res; 1999 Mar; 22(1):49-54. PubMed ID: 10221351
[TBL] [Abstract][Full Text] [Related]
2. Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet.
Miyazaki M; Sakonjo H; Takai S
Br J Pharmacol; 1999 Oct; 128(3):523-9. PubMed ID: 10516628
[TBL] [Abstract][Full Text] [Related]
3. High resolution miniature trans-esophageal echocardiography is useful to evaluate atherosclerosis and the effects of alacepril in hyper-cholesterol rabbits.
Yoshida S; Itoh K
Jpn Heart J; 1994 Nov; 35(6):789-9. PubMed ID: 7897825
[TBL] [Abstract][Full Text] [Related]
4. Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeys.
Song K; Shiota N; Takai S; Takashima H; Iwasaki H; Kim S; Miyazaki M
Atherosclerosis; 1998 May; 138(1):171-82. PubMed ID: 9678783
[TBL] [Abstract][Full Text] [Related]
5. The ACE inhibitor alacepril suppresses atherogenesis independent of serum lipids in cholesterol-fed rabbits--critical analysis with new ultrasound technique.
Itoh K; Yoshida S; Fukuda M
Jpn Circ J; 1994 Nov; 58(11):844-54. PubMed ID: 7807684
[TBL] [Abstract][Full Text] [Related]
6. Effects of alacepril and amlodipine on the renal injury induced by a high-cholesterol diet in rats.
Atarashi K; Takagi M; Minami M; Ishiyama A
J Hypertens; 1999 Dec; 17(12 Pt 2):1983-6. PubMed ID: 10703899
[TBL] [Abstract][Full Text] [Related]
7. Regression of early atherosclerosis in hyperlipidemic hamsters induced by fosinopril and captopril.
Kowala MC; Recce R; Beyer S; Aberg G
J Cardiovasc Pharmacol; 1995 Feb; 25(2):179-86. PubMed ID: 7752642
[TBL] [Abstract][Full Text] [Related]
8. Delapril slows the progression of atherosclerosis and maintains endothelial function in cholesterol-fed rabbits.
Hernandez A; Barberi L; Ballerio R; Testini A; Ferioli R; Bolla M; Natali M; Folco G; Catapano AL
Atherosclerosis; 1998 Mar; 137(1):71-6. PubMed ID: 9568738
[TBL] [Abstract][Full Text] [Related]
9. Effect of antihypertensive treatment with alacepril on insulin resistance in diabetic spontaneously hypertensive rats.
Sato T; Nara Y; Kato Y; Yamori Y
Metabolism; 1996 Apr; 45(4):457-62. PubMed ID: 8609831
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of AT1 receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis.
Hope S; Brecher P; Chobanian AV
Am J Hypertens; 1999 Jan; 12(1 Pt 1):28-34. PubMed ID: 10075381
[TBL] [Abstract][Full Text] [Related]
11. Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits: effects of enalapril.
Hoshida S; Nishida M; Yamashita N; Igarashi J; Aoki K; Hori M; Kuzuya T; Tada M
Atherosclerosis; 1997 Apr; 130(1-2):53-9. PubMed ID: 9126648
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of angiotensin II type 1 receptor blocker for anti-atherosclerotic effect in monkeys fed a high-cholesterol diet.
Takai S; Kim S; Sakonjo H; Miyazaki M
J Hypertens; 2003 Feb; 21(2):361-9. PubMed ID: 12569267
[TBL] [Abstract][Full Text] [Related]
13. Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.
de Nigris F; D'Armiento FP; Somma P; Casini A; Andreini I; Sarlo F; Mansueto G; De Rosa G; Bonaduce D; Condorelli M; Napoli C
Int J Cardiol; 2001 Dec; 81(2-3):107-15; discusssion 115-6. PubMed ID: 11744122
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389
[TBL] [Abstract][Full Text] [Related]
15. Antiatherogenic effect of angiotensin converting enzyme inhibitor (benazepril) and angiotensin II receptor antagonist (valsartan) in the cholesterol-fed rabbits.
Li J; Hirose N; Kawamura M; Arai Y
Atherosclerosis; 1999 Apr; 143(2):315-26. PubMed ID: 10217360
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics of alacepril in healthy cats.
Sugimoto K; Fujii Y; Takubo I; Shiga T; Sunahara H; Aoki T; Orito K
J Feline Med Surg; 2017 Jun; 19(6):706-709. PubMed ID: 26927816
[TBL] [Abstract][Full Text] [Related]
17. ACE-inhibitors and atherosclerosis.
Ambrosioni E; Bacchelli S; Degli Esposti D; Borghi C
Eur J Epidemiol; 1992 May; 8 Suppl 1():129-33. PubMed ID: 1324185
[TBL] [Abstract][Full Text] [Related]
18. Tissue levels, tissue angiotensin converting enzyme inhibition and antihypertensive effect of the novel antihypertensive agent alacepril in renal hypertensive rats.
Nambu K; Matsumoto K; Takeyama K; Hosoki K; Miyazaki H; Hashimoto M
Arzneimittelforschung; 1986; 36(1):47-51. PubMed ID: 3006710
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin converting enzyme inhibitors and atherosclerosis.
Andersson RG; Jacobsson L; Persson K
J Physiol Pharmacol; 1994 Mar; 45(1):13-25. PubMed ID: 8043902
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effect of an angiotensin-converting enzyme inhibitor, alacepril, on drug-induced renin-angiotensin-aldosterone system activation in normal dogs.
Sakatani A; Miyagawa Y; Takemura N
J Vet Cardiol; 2016 Sep; 18(3):248-254. PubMed ID: 27364087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
